Showing results (1131-1140 of 6,769) with videos related to
Sort By:
Pageof 677
Clinical Therapeutics|March 24, 2009
Pharmacokinetics, bioequivalence, tolerability, and effects on platelet counts of two formulations of anagrelide in healthy volunteers and patients with thrombocythemia associated with chronic myeloproliferationPetro E Petrides, Heinz Gisslinger, Michael Steurer, et al.Clinical Therapeutics|March 24, 2009
Bioequivalence of single 100-mg doses of two oral formulations of topiramate: an open-label, randomized-sequence, two-period crossover study in healthy adult male Mexican volunteersAlfredo Piñeyro-López, Everardo Piñeyro-Garza, Magdalena Gómez-Silva, et al.Clinical Therapeutics|March 14, 2009
Angiotensin II receptor blockers in the treatment of the cardiovascular disease continuumSteven G ChrysantClinical Therapeutics|March 14, 2009
Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarctionShawn X Sun, Xiaolan Ye, Kwan Y Lee, et al.Clinical Therapeutics|March 14, 2009
Long-term persistence with statin therapy: a nationwide register study in FinlandArja Helin-Salmivaara, Piia Lavikainen, Maarit J Korhonen, et al.Clinical Therapeutics|March 14, 2009
Prescribing of beta-blockers after myocardial infarction: a preliminary study of physician motivations and barriersJan Kavookjian, Sekhar MamidiClinical Therapeutics|September 1, 1990
Effects of a protein-bound polysaccharide from a basidiomycetes against hepatocarcinogenesis induced by 3'-methyl-4-dimethylaminoazobenzene in ratsT Nakajima, S Ichikawa, S Uchida, et al.Clinical Therapeutics|August 19, 2007
Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trialKeith Aqua, Joseph S Gimbel, Neil Singla, et al.Clinical Therapeutics|August 19, 2007
Clinical evaluation of novel bisphosphonate dosing regimens in osteoporosis: the role of comparative studies and implications for future studiesFelicia Cosman, Joao L C Borges, Manuel Diaz CurielClinical Therapeutics|August 19, 2007
Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjectsJose Antonio Palma-Aguirre, Jose Antonio Absalón-Reyes, Germán Novoa-Heckel, et al.Pageof 677